Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis

Supporting evidence

• Review decision

• Review decision – December 2018

• Review decision paper (PDF 272 KB)

  Published:

  31 December 2018

• Matrix of stakeholders (PDF 263 KB)

  Published:

  31 December 2018